Kay Warner is a Director within the Patients in Partnership team at GlaxoSmithKline Research and Development. Kay moved to her current role as Patient Engagement Lead in January 2017 and is patient engagement subject matter expert at GSK having interacted with many individual patients, caregivers, patient advocates, patient advocacy organisations in the last 13 years. With her passion to make a difference, Kay is working to strengthen the patient voice in medicines development and research at key decision time points. She also represents GSK in the European Patients’ Academy (EUPATI) project. She is also supporting the IMI2 project Patients Active in Research and Dialogues for an Improved Generation of Medicines (PARADIGM).